Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 42 (4) , 233-246
- https://doi.org/10.1016/s0006-3223(97)00190-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Activity of “Seroquel” (ICI 204,636) in Animal Models for Atypical Properties of Antipsychotics: A Comparison with ClozapineNeuropsychopharmacology, 1996
- ICI 204,636, an Atypical AntipsychoticJournal of Clinical Psychopharmacology, 1996
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophreniaClinical Therapeutics, 1995
- Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus HaloperidolThe British Journal of Psychiatry, 1995
- Section Review—Central & Peripheral Nervous Systems: Pre-Clinical Pharmacology of New Atypical Antipsychotics in Late Stage DevelopmentExpert Opinion on Investigational Drugs, 1995
- Risperidone in the treatment of schizophreniaAmerican Journal of Psychiatry, 1994
- Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drugPsychopharmacology, 1993
- Carbamazepine and Thyroid Function in Affectively Ill PatientsArchives of General Psychiatry, 1984
- The Brief Psychiatric Rating ScalePsychological Reports, 1962